EPHA4 and atypical Rett syndrome: Moreover, miR-21-5p from human urine-derived stem cell-derived EVs attenuated Rett syndrome, an early cognitive loss and neurologic deterioration disease, through the inhibition of Eph receptor A4 (Epha4) and its downstream signaling TEX [141].